Announcements Trials
Browse Landscape

Phase

Phase 3 15Phase NA 12Phase 4 11Phase 2 11Phase 2/3 7Phase EARLY_PHASE1 6Phase 1/2 4Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Pelvic Neoplasms 1Pain, Postoperative 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Ketamine × Clear all
NCT06631625 2024-10-08

Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

Alexandria University

Phase 1 Completed
45 enrolled
Gynecologic

Pelvic Neoplasms

NCT05536362 2022-10-26

Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery

Egymedicalpedia

Phase 1 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡